 |
|
X-linked Bulbospinal Neuronopathy
Kennedy Disease
Anne D. Sperfeld, MD;
Jochem Karitzky, MD;
Dagmar Brummer, MD;
Herbert Schreiber, MD;
Jürgen Häussler, MD;
Albert C. Ludolph, MD;
C. Oliver Hanemann, MD
Arch Neurol. 2002;59:1921-1926.
Objective To characterize the earliest symptoms of X-linked bulbospinal neuronopathy (Kennedy disease [KD]) during the course of the disease, including a definition of the age of onset.
Methods We describe the earliest symptoms, signs on clinical investigation, electrophysiological and muscle biopsy specimen findings, and creatine kinase levels in 34 patients with KD. Correlations were made among the CAG-repeat length and clinical symptoms, age at onset, and the presence of electrophysiological and laboratory findings.
Results Our findings indicate that the age at onset of KD is in adolescence which is earlier than previously thought. Most frequently early symptoms are gynecomastia, muscle pain, and premature muscular exhaustion. Weakness is not a typical initial symptom and is frequently found in distal limbs if present early. We found a correlation between the of number of CAG repeats and the age at onset of weakness but not to the age at onset of KD. Furthermore, no correlations were found between the occurrence of gynecomastia, tremor, increased creatine kinase levels, and additional myopathic changes in muscle biopsy specimens.
Conclusions Our data show that KD is a multisystem disorder with onset in adolescence. Because of the heterogeneity of clinical presentation and no correlation between the number of CAG repeats and most of the clinical hallmarks of KD, we suggest that other environmental or genetic factors contribute to the manifestation of specific organ systems in KD.
From the Departments of Neurology (Drs Sperfeld, Karitzky, Brummer, Schreiber, Ludolph, and Hanemann) and Human Genetics (Dr Häussler), University of Ulm, Ulm, Germany.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice
Yu et al.
DMM 2009;2:500-507.
ABSTRACT
| FULL TEXT
CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA
Suzuki et al.
Brain 2008;131:229-239.
ABSTRACT
| FULL TEXT
Widespread white matter changes in Kennedy disease: a voxel based morphometry study
Kassubek et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1209-1212.
ABSTRACT
| FULL TEXT
Genetics of essential tremor
Deng et al.
Brain 2007;130:1456-1464.
ABSTRACT
| FULL TEXT
CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model
Adachi et al.
J. Neurosci. 2007;27:5115-5126.
ABSTRACT
| FULL TEXT
Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis
Takeshita et al.
Hum Mol Genet 2006;15:2298-2312.
ABSTRACT
| FULL TEXT
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients
Atsuta et al.
Brain 2006;129:1446-1455.
ABSTRACT
| FULL TEXT
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients
Adachi et al.
Brain 2005;128:659-670.
ABSTRACT
| FULL TEXT
Laryngospasm: An underdiagnosed symptom of X-linked spinobulbar muscular atrophy
Sperfeld et al.
Neurology 2005;64:753-754.
ABSTRACT
| FULL TEXT
Kennedy Disease: Insights and Questions
Paparounas
Arch Neurol 2004;61:603-603.
FULL TEXT
Kennedy Disease: Insights and Questions--Reply
Sperfeld and Hanemann
Arch Neurol 2004;61:603-604.
FULL TEXT
Use of epidural anaesthesia for surgery in a patient with Kennedy's disease
Okamoto et al.
Br J Anaesth 2004;92:432-433.
ABSTRACT
| FULL TEXT
|
